Urgent Notice to All Conference Participants

It has been brought to our attention that EHS Housing has recently been cold calling our speakers offering accommodation for a named Fusion conference. Please note that we have no association with EHS Housing and they are acting on our behalf without our permission. We strongly advise that any calls from EHS Housing are ignored or ended immediately. If you are contacted by EHS Housing, please notify us immediately.

All Fusion registration fees are inclusive of accommodation (for three fixed nights) and reservations are handled internally, entirely by Fusion Conferences. If you have any questions concerning your accommodation, please contact Fusion Conferences directly via admin@fusion-conferences.com.

Latest News:
Follow us

Home > Past Conferences > Antiviral

The registration process for this conference has now closed.

Registration Deadlines

Early bird – expired

Talk Submission – expired

Poster Submission – expired

Last Chance – expired


28 Sep 14 - 01 Oct 14

El Jadida, Morocco


*Thank you to our media partners; the European Society for Virology and the Journal of General Virology.*

The four day conference will focus on Antiviral Research with a combination of plenary lectures, invited lectures and contributing talks which will be selected from the open abstract submissions (submissions can be uploaded upon registration). A broad range of topics will be covered focusing on the latest clinical practice, as well as the discovery and development of antiviral agents for the treatment and cure of various infectious agents. 

Key Sessions

  • HIV (Treatment)
  • HIV (Eradication)
  • HBV
  • HCV
  • Respiratory Viruses
  • Vector Borne Viruses
  • Norovirus & Emerging Viruses
  • Herpes Viruses
  • Global Pandemics

Our speakers will discuss the latest developments and cutting edge research and look to address the question “What is next for the industry?” The purpose of this conference is to provide a platform for discussion, collaboration and free exchange of ideas, allowing all participants to present their work either as a talk or in poster form. 

Educational Objectives

The conference will address the following learning objectives:

  1. Update participants on the overall progress in antiviral research
  2. Inform clinicians of their choices in patient treatments with existing licenced antiviral therapies
  3. Describe the pipeline of new compounds in development and their likely impact on patient treatments
  4. Enhance the understanding of participants of the development of resistance to antiviral drugs and the importance of treatment selection and adherence to the correct dosing regimens
  5. Evaluate the unmet needs for antiviral drugs to guide both academic and industry participants in their choice of research topics
  6. Help participants foresee the impact of the latest discoveries in virology on the search for new therapies.

Target Audience

This conference will look to bridge the gap between clinical practise, industry and academia and will actively encourage the participation MDs, clinicians, nurses, clinical lab directors, clinical service planners, academic researchers and pharmaceutical industry representatives.

Confirmed Plenary Speakers

Daria Hazuda
Mario Stevenson
University of Miami Health System
Michael Manns
Hannover Medical School 
Guey Chuen (Oscar) Perng
National Cheng Kung University
Brent Korba
Georgetown University
Helga Rubsamen-Schaeff
Yves Benhamou
Hôpital Pitié-Salpêtrière

Confirmed Invited Speakers

Baek Kim
Emory University
Carol Brosgart
Viral Hepatitis Action Coalition, CDC Foundation
Leonid Margolis
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Massimo Levrero
Sapienza Universita' di Roma
Osvaldo (Lalo) Flores
Novira Therapeutics 
Tarik Asselah
University Paris Diderot






Plenary Speakers

Invited Speakers

  • Dr. Baek Kim
    Director of Drug Discovery, Emory University
  • Prof. Massimo Levrero
    Professor of Medicine, Sapienza University of Rome
  • President & CSO Lalo Flores
    President & CSO, Novira Therapeutics
  • Dr. Leonid Margolis
    Section Chief, NIH
  • Prof. Dr. Tariq Rana
    Professor and V/C, UCSD School of Medicine


Sign In

Your feedback has been received.

Cant see images? See gallery on Flickr